#Israel #Ramat Gan #Pulsenmore #Clalit #IVF service

Transforming Fertility Care: At-Home Follicular Monitoring

In a significant development for fertility treatments, Pulsenmore Ltd. (NASDAQ: PLSM), a pioneer in connected home ultrasound technology, has partnered with Clalit Health Services, Israel's largest health maintenance organization (HMO). This collaboration aims to deliver the first-ever at-home follicular monitoring service, enhancing the IVF and fertility preservation processes for patients.

Introduction to At-Home Monitoring

Traditionally, fertility treatment has relied heavily on frequent clinic visits for transvaginal ultrasound scans, which can disrupt patients' daily lives and cause added stress. Recognizing the need for a more accommodating approach, Pulsenmore is introducing the Pulsenmore FC — an innovative ultrasound device that allows patients to conduct follicular monitoring from the comfort of their own homes. The service is expected to be integrated into the Beilinson NEXT virtual hospital system, making it accessible to eligible patients.

The implementation of this technology follows successful pilot studies demonstrating its clinical efficacy and reliability. In June 2025, results from controlled clinical trials at Beilinson Medical Center confirmed a strong safety profile and high concordance between at-home ultrasound measurements and traditional in-clinic assessments.

How It Works

The enhanced service leverages Pulsenmore FC and a complementary mobile application that guides users through the scanning process. Patients can perform the follicular monitoring scans independently, while healthcare professionals provide real-time support and oversight online. Secure data transmission capabilities ensure that the collected scan data is sent directly to the Beilinson NEXT care team for monitoring and evaluation.

This innovative solution serves several critical functions — it facilitates monitoring of follicular development and endometrial thickness, essential for accurate timing of crucial treatment injections and egg retrieval. By reducing the number of required in-clinic visits, Pulsenmore FC not only promotes patient convenience but also contributes to better patient satisfaction and outcomes.

A New Standard in Healthcare Delivery

Dr. Elazar Sonnenschein, CEO and founder of Pulsenmore, expressed optimism about the transformative potential of this agreement, stating, "We are enabling a new model of care that respects patients' time, privacy, and daily lives while maintaining clinical oversight." He credited Clalit for breaking new ground and setting a standard that prioritizes connected, empathetic care from home.

Clalit’s CEO, Dr. Eytan Wirtheim, echoed these sentiments, highlighting the service's alignment with Clalit’s strategic vision: "Any medical service that can be offered from home, without compromising quality, will be made available." This reflects a larger trend in healthcare where the focus is shifting towards patient-oriented services that minimize disruptions to their lives.

The pilot phase of the program will initially serve a limited group of women, with plans for a broader rollout in the future. As the program expands, there is great confidence that the at-home monitoring services will be well received by patients unfamiliar with such accessible solutions in fertility care.

Looking Beyond

In addition to the Pulsenmore FC, Pulsenmore’s partnership with Clalit also includes the provision of Pulsenmore ES, a physician-supervised home prenatal ultrasound solution. Approved for commercial use in Israel, this device highlights Pulsenmore's commitment to enhancing maternal health and improving care continuity through telemedicine.

With the healthcare landscape evolving, Pulsenmore's innovations symbolize a pivotal shift towards patient-centric models of care. These advancements promise to not only facilitate improved treatment outcomes but also empower patients in their healthcare journeys. As more patients embrace these solutions, Pulsenmore and Clalit are poised to redefine the standards of fertility care — bridging the gap between technology and compassionate healthcare delivery.

For those interested in learning more about Pulsenmore’s revolutionary approach to home ultrasound technology, additional information is available at Pulsenmore’s official website.